Rachel M. Levine

Ex vivo prime editing of patient haematopoietic stem cells rescues sickle-cell disease phenotypes after engraftment in mice

Kelcee A. Everette, Gregory A. Newby, Rachel M. Levine et al. · Nature Biomedical Engineering · 2023 · 125 citations · Full text

Clinical History of the Theranostic Radionuclide Approach to Neuroendocrine Tumors and Other Types of Cancer: Historical Review Based on an Interview of Eric P. Krenning by Rachel Levine

Rachel M. Levine, Eric P. Krenning · Journal of Nuclear Medicine · 2017 · 97 citations · Full text

Engineering, Theranostic Radionuclide Approach, Rachel Levine +22

Bone-marrow-homing lipid nanoparticles for genome editing in diseased and malignant haematopoietic stem cells

Xizhen Lian, Sumanta Chatterjee, Yehui Sun et al. · Nature Nanotechnology · 2024 · 97 citations · Full text

Medicine, Stem Cell Mobilization, Stem Cells +8

Peptide functionalized nanoparticles for nonviral gene delivery

Rachel M. Levine, Carolyn Scott, Efrosini Kokkoli · Soft Matter · 2012 · 76 citations

Nanoparticles, Engineering, Peptide Engineering +16

Dihydrofolate reductase gene amplification and possible rearrangement in estrogen-responsive methotrexate-resistant human breast cancer cells.

Kenneth H. Cowan, Merrill E. Goldsmith, Rachel M. Levine et al. · Journal of Biological Chemistry · 1982 · 74 citations · Full text

Breast Oncology, Genetics, Molecular Biology +19